AntibioticMech

nevirapine

CHEBI:63613 ·resolve ·ANTIVIRAL ·EXACT SEEDED

A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection. — ChEBI

Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.

Classification

Strictly broader compounds or drug classes this molecule belongs to.

Chemical structure

Computed structure properties
Molecular formulaC15H14N4O
Charge0
Average mass266.304 Da
Monoisotopic mass266.11676 Da
SourceChEBI
InChIKeyNQDJXKOVJZTUJA-UHFFFAOYSA-N

SMILES

Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1

InChI

InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)

Also called

Cross-references

Equivalent identifiers for this same structure in other resources.

Activity roles

Every antimicrobial role a source asserts for this compound — the unreduced evidence behind its antimicrobial_class.

Source concepts

Every upstream concept that resolved to this record. The merge is the product: this is what shows ChEBI and CARD are describing the same structure.

Upstream concepts merged into this record
SourceNative IDLabelMinted CURIEVersion
CHEBI CHEBI:63613 nevirapine antibioticmech:chebi-5176020c8d 2026-08-30

Molecular targets

The molecular entity or process this compound acts on. Each target carries evidence — this is a mechanistic claim, not a classification.

Dimer of Gag-Pol polyprotein [600-1159,L699I,K702N,C879S] VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 1 NCBITaxon:11676

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
IC50 77200 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 29397
assay 2026_1
monomer 1434
PMID:17458947
Organism-specific examples
ProteinGeneOrganismEntry
Gag-Pol polyprotein UniProtKB:P03366 Human immunodeficiency virus 1 REVIEWED

Gag-Pol polyprotein [588-1027,K690N]/[588-1147,K690N] VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 1 NCBITaxon:11676

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
IC50 57900 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 2784
assay 426_1
monomer 1434
PMID:7683725
IC50 3800 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 3491
assay 457_1
monomer 1434
PMID:10514285
IC50 1100 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 8166
assay 695_1
monomer 1434
PMID:15519161
Organism-specific examples
ProteinGeneOrganismEntry
Gag-Pol polyprotein UniProtKB:P04585 Human immunodeficiency virus 1 REVIEWED

Gag-Pol polyprotein [588-1027,K691N]/[588-1147,K690N] VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 1 NCBITaxon:11676

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
KI 7000 nM Reverse Transcriptase Assay
The inhibition of the RNA-dependent DNA polymerase activity of the HIV-1 reverse transcriptase enzyme was measured using a primer extension assay. The substrate-incorporated radioactivity was quantitated by scintillation counting.
RSID 50480
assay 3068_1
monomer 1434
PMID:19170521
Organism-specific examples
ProteinGeneOrganismEntry
Gag-Pol polyprotein UniProtKB:P04585 Human immunodeficiency virus 1 REVIEWED

Gag-Pol polyprotein [588-1027,P823L]/[588-1147,P823L] VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 1 NCBITaxon:11676

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
IC50 320 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 3263
assay 402_1
monomer 1434
PMID:8809165
Organism-specific examples
ProteinGeneOrganismEntry
Gag-Pol polyprotein UniProtKB:P04585 Human immunodeficiency virus 1 REVIEWED

Gag-Pol polyprotein [588-1027,V694A]/[588-1147,V694A] VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 1 NCBITaxon:11676

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
KI 10000 nM Reverse Transcriptase Assay
The inhibition of the RNA-dependent DNA polymerase activity of the HIV-1 reverse transcriptase enzyme was measured using a primer extension assay. The substrate-incorporated radioactivity was quantitated by scintillation counting.
RSID 50488
assay 3068_1
monomer 1434
PMID:19170521
Organism-specific examples
ProteinGeneOrganismEntry
Gag-Pol polyprotein UniProtKB:P04585 Human immunodeficiency virus 1 REVIEWED

Gag-Pol polyprotein [588-1027,V767D]/[588-1147,V767D] VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 1 NCBITaxon:11676

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
KI 2000 nM Reverse Transcriptase Assay
The inhibition of the RNA-dependent DNA polymerase activity of the HIV-1 reverse transcriptase enzyme was measured using a primer extension assay. The substrate-incorporated radioactivity was quantitated by scintillation counting.
RSID 50493
assay 3068_1
monomer 1434
PMID:19170521
Organism-specific examples
ProteinGeneOrganismEntry
Gag-Pol polyprotein UniProtKB:P04585 Human immunodeficiency virus 1 REVIEWED

Gag-Pol polyprotein [588-1027,Y769I]/[588-1147,Y769I] VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 1 NCBITaxon:11676

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
KI 36000 nM Reverse Transcriptase Assay
The inhibition of the RNA-dependent DNA polymerase activity of the HIV-1 reverse transcriptase enzyme was measured using a primer extension assay. The substrate-incorporated radioactivity was quantitated by scintillation counting.
RSID 50485
assay 3068_1
monomer 1434
PMID:19170521
Organism-specific examples
ProteinGeneOrganismEntry
Gag-Pol polyprotein UniProtKB:P04585 Human immunodeficiency virus 1 REVIEWED

Gag-Pol polyprotein [588-1027,Y776L]/[588-1147,Y776L] VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 1 NCBITaxon:11676

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
KI 18000 nM Reverse Transcriptase Assay
The inhibition of the RNA-dependent DNA polymerase activity of the HIV-1 reverse transcriptase enzyme was measured using a primer extension assay. The substrate-incorporated radioactivity was quantitated by scintillation counting.
RSID 50496
assay 3068_1
monomer 1434
PMID:19170521
Organism-specific examples
ProteinGeneOrganismEntry
Gag-Pol polyprotein UniProtKB:P04585 Human immunodeficiency virus 1 REVIEWED

Gag-Pol polyprotein [588-1027]/[588-1147] VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 1 NCBITaxon:11676

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
IC50 430 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 1560
assay 375_1
monomer 1434
PMID:7689109
IC50 200 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 2056
assay 399_1
monomer 1434
PMID:8523406
IC50 3100 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 2136
assay 402_1
monomer 1434
PMID:8809165
IC50 200 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 2637
assay 416_1
monomer 1434
PMID:8863804
IC50 101 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 2776
assay 426_1
monomer 1434
PMID:7683725
IC50 5500 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 2817
assay 427_1
monomer 1434
PMID:7684450
IC50 300 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 2850
assay 429_1
monomer 1434
PMID:11472208
IC50 600 nM HIV RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV RT RNA-directed DNA polymerase activity in vitro.
RSID 2862
assay 430_1
monomer 1434
PMID:8558522
IC50 300 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 2929
assay 431_1
monomer 1434
PMID:10052969
IC50 640 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 2943
assay 433_1
monomer 1434
PMID:10794705
IC50 270 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 2966
assay 435_1
monomer 1434
PMID:9154967
IC50 700 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 3019
assay 438_1
monomer 1434
PMID:8818233
IC50 2800 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 3033
assay 439_1
monomer 1434
PMID:12773052
IC50 170 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 3475
assay 457_1
monomer 1434
PMID:10514285
IC50 4848 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 3662
assay 467_1
monomer 1434
PMID:10821714
IC50 2.6 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 8159
assay 695_1
monomer 1434
PMID:15519161
IC50 200 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 18551
assay 1334_1
monomer 1434
PMID:11052800
IC50 300 nM HIV-1 RT Assay.
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 21759
assay 1549_1
monomer 1434
PMID:15537346
Organism-specific examples
ProteinGeneOrganismEntry
Gag-Pol polyprotein UniProtKB:P04585 Human immunodeficiency virus 1 REVIEWED

Gag-Pol polyprotein [588-1127,L687I]/[588-1147,L687I] VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 1 NCBITaxon:11676

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
IC50 11800 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 2638
assay 416_1
monomer 1434
PMID:8863804
IC50 3500 nM HIV RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV RT RNA-directed DNA polymerase activity in vitro.
RSID 2875
assay 430_1
monomer 1434
PMID:8558522
IC50 >100000 nM HIV-1 RT Assay.
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 21769
assay 1549_1
monomer 1434
PMID:15537346
KI 9000 nM Reverse Transcriptase Assay
The inhibition of the RNA-dependent DNA polymerase activity of the HIV-1 reverse transcriptase enzyme was measured using a primer extension assay. The substrate-incorporated radioactivity was quantitated by scintillation counting.
RSID 50475
assay 3068_1
monomer 1434
PMID:19170521
Organism-specific examples
ProteinGeneOrganismEntry
Gag-Pol polyprotein UniProtKB:P04585 Human immunodeficiency virus 1 REVIEWED

Gag-Pol polyprotein [588-1127,Y768C]/[588-1147,Y768C] VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 1 NCBITaxon:11676

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
IC50 201000 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 2639
assay 416_1
monomer 1434
PMID:8863804
IC50 11300 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 2792
assay 426_1
monomer 1434
PMID:7683725
IC50 >20000 nM HIV RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV RT RNA-directed DNA polymerase activity in vitro.
RSID 2869
assay 430_1
monomer 1434
PMID:8558522
IC50 >60000 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 3278
assay 402_1
monomer 1434
PMID:8809165
IC50 >50000 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 3483
assay 457_1
monomer 1434
PMID:10514285
IC50 1900 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 8173
assay 695_1
monomer 1434
PMID:15519161
IC50 >100000 nM HIV-1 RT Assay.
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 21764
assay 1549_1
monomer 1434
PMID:15537346
Organism-specific examples
ProteinGeneOrganismEntry
Gag-Pol polyprotein UniProtKB:P04585 Human immunodeficiency virus 1 REVIEWED

Gag-Pol polyprotein [600-1027,K702N]/[600-1155,K702N] VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 1 NCBITaxon:11676

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
IC50 1900 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 2477
assay 410_1
monomer 1434
PMID:9685235
Organism-specific examples
ProteinGeneOrganismEntry
Gag-Pol polyprotein UniProtKB:P03366 Human immunodeficiency virus 1 REVIEWED

Gag-Pol polyprotein [600-1027,P835L]/[600-1155,P835L] VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 1 NCBITaxon:11676

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
IC50 80 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 2478
assay 410_1
monomer 1434
PMID:9685235
Organism-specific examples
ProteinGeneOrganismEntry
Gag-Pol polyprotein UniProtKB:P03366 Human immunodeficiency virus 1 REVIEWED

Gag-Pol polyprotein [600-1027,R876K]/[600-1155] VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 1 NCBITaxon:11676

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
IC50 80 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 1642
assay 382_1
monomer 1434
PMID:7490732
IC50 80 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 1762
assay 386_1
monomer 1434
PMID:7490733
IC50 84 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 1854
assay 389_1
monomer 1434
PMID:1712395
Organism-specific examples
ProteinGeneOrganismEntry
Gag-Pol polyprotein UniProtKB:P03366 Human immunodeficiency virus 1 REVIEWED

Gag-Pol polyprotein [600-1027,Y780C]/[600-1155,Y780C] VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 1 NCBITaxon:11676

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
IC50 2600 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 1657
assay 382_1
monomer 1434
PMID:7490732
IC50 2600 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 1782
assay 386_1
monomer 1434
PMID:7490733
Organism-specific examples
ProteinGeneOrganismEntry
Gag-Pol polyprotein UniProtKB:P03366 Human immunodeficiency virus 1 REVIEWED

Gag-Pol polyprotein [600-1029,C879S]/[600-1159,C879S] VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 1 NCBITaxon:11676

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
IC50 1700 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 29395
assay 2026_1
monomer 1434
PMID:17458947
Organism-specific examples
ProteinGeneOrganismEntry
Gag-Pol polyprotein UniProtKB:P03366 Human immunodeficiency virus 1 REVIEWED

Gag-Pol polyprotein [600-1159,Y780C]/Imidazoleglycerol-phosphate dehydratase [600-1029,Y780C] VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 1 NCBITaxon:11676

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
IC50 100000 nM HIV-1 RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.
RSID 29396
assay 2026_1
monomer 1434
PMID:17458947
Organism-specific examples
ProteinGeneOrganismEntry
Gag-Pol polyprotein UniProtKB:P03366 Human immunodeficiency virus 1 REVIEWED
Imidazoleglycerol-phosphate dehydratase UniProtKB:P06633 Human immunodeficiency virus 1 REVIEWED

Gag-Pol polyprotein [613-1167,R896S,E946D,S1117V]/[618-1043,R896S,E946D] VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 2 NCBITaxon:11709

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
IC50 >20000 nM HIV RT Assay
The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV RT RNA-directed DNA polymerase activity in vitro.
RSID 2879
assay 430_1
monomer 1434
PMID:8558522
Organism-specific examples
ProteinGeneOrganismEntry
Gag-Pol polyprotein UniProtKB:P04584 Human immunodeficiency virus 2 REVIEWED

Reverse transcriptase VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 2 NCBITaxon:11709

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
IC50 4.20e+3 nM In Vitro Enzyme Assay
The reverse transcriptase inhibitory activity of compound was evaluated by a non-radioactive colorimetric assay method. This procedure uses RT to synthesize DNA starting from the template/primer hybridpoly (A) x oligo (dT)15 and avoids the use of radio-labeled nucleotides.
RSID 159029
assay 4807_1
monomer 1434
PMID:19703027
Organism-specific examples
ProteinGeneOrganismEntry
Reverse transcriptase UniProtKB:Q06347 Human immunodeficiency virus 2 UNREVIEWED

Reverse transcriptase protein VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Human immunodeficiency virus 1 NCBITaxon:11676

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
IC50 5.8e+2 nM In vitro Anti-HIV RT Assay
The HIV-1 RTwt inhibition assay was implemented using the template/primer hybrid poly(A)9oligo(dT)15, digoxigenin- and biotin-labeled nucleotides, an antibody to digoxigenin which is conjugated to peroxidase (anti-DIG-POD), and the peroxidase substrate ABTS for quantifying the RT polymerase activity. The incorporation quantities of the digoxigenin- and biotin-labeled dUTP into DNA represented the activity of HIV-1 RT. The IC50 value corresponds to the concentration of the tested compound required to inhibit the incorporation of the labeled dUTP by 50%. The procedure for RT assay was performed as described in the kit (Roche) protocol
RSID 306799
assay 6988_1
monomer 1434
PMID:25511999
IC50 1.6e+4 nM HIV-1 RT Inhibitory Assay
The NNRTI compound to be evaluated (NVP) was serially diluted in 50% DMSO. The reaction mixtures containing 150 nM labeled primer−template hybrid, 100 μM dATP, 0.25 or 6 mM free Mg2+ (adjusted according to the concentration of dATP), and 5% DMSO were preincubated at 37 °C for 3 min in a total volume of 8.5 μL of reaction buffer (see above). Twenty-five nM HIV-1 or K103N RT (at similar activities of primer extension) was preincubated with different dilutions of NVP (as noted in the figure legends) for 10 min at room temperature. Reaction was then initiated by adding the NVP/ RT mix to the primer−template hybrid. The final pH of the reactions was 7.7. After extension for 3 min, the reactions were stopped by adding 12.5 μL of 2× gel loading buffer and the samples were resolved in a 16% denaturing polyacrylamide−7 M urea gel.
RSID 370981
assay 7676_1
monomer 1434
PMID:27936595
IC50 4.3e+3 nM HIV-1 RT Inhibitory Assay
The NNRTI compound to be evaluated (NVP) was serially diluted in 50% DMSO. The reaction mixtures containing 150 nM labeled primer−template hybrid, 100 μM dATP, 0.25 or 6 mM free Mg2+ (adjusted according to the concentration of dATP), and 5% DMSO were preincubated at 37 °C for 3 min in a total volume of 8.5 μL of reaction buffer (see above). Twenty-five nM HIV-1 or K103N RT (at similar activities of primer extension) was preincubated with different dilutions of NVP (as noted in the figure legends) for 10 min at room temperature. Reaction was then initiated by adding the NVP/ RT mix to the primer−template hybrid. The final pH of the reactions was 7.7. After extension for 3 min, the reactions were stopped by adding 12.5 μL of 2× gel loading buffer and the samples were resolved in a 16% denaturing polyacrylamide−7 M urea gel.
RSID 370982
assay 7676_1
monomer 1434
PMID:27936595
Organism-specific examples
ProteinGeneOrganismEntry
Reverse transcriptase protein UniProtKB:Q9WJQ1 Human immunodeficiency virus 1 UNREVIEWED

Mechanism summary

Mode of action
VIRAL_POLYMERASE_INHIBITION microbial target — Assigned from ChEBI role CHEBI:53756 (HIV-1 reverse transcriptase inhibitor). ChEBI asserts the role on the compound. The role names a target specific to the microbe or virus — see mode_of_action_target_scope. Not a curator's mechanistic review.
Clinical status
APPROVED

Causal graphs

Evidence-backed mechanism graphs: how the compound reaches its target, what the target does, and how the effect propagates to growth inhibition or death.

Nevirapine allosterically inhibits HIV-1 reverse transcriptase MECHANISTIC

Nevirapine binds the non-nucleoside inhibitor pocket of HIV-1 reverse transcriptase, distorts the polymerase active-site geometry, and prevents RNA-templated viral DNA synthesis.

Nodes — nevirapine_hiv1_reverse_transcriptase_inhibition
NodeLabelTypeGrounding
nevirapine nevirapine COMPOUND CHEBI:63613
hiv1_reverse_transcriptase HIV-1 reverse transcriptase GENE_OR_PROTEIN REVIEWED_LABEL_ONLY
nnrti_pocket HIV-1 reverse transcriptase non-nucleoside inhibitor pocket STATE REVIEWED_LABEL_ONLY
primer_active_site_alignment DNA primer 3' end aligned with the polymerase active site STATE REVIEWED_LABEL_ONLY
rna_directed_dna_polymerase_activity RNA-directed DNA polymerase activity MOLECULAR_FUNCTION GO:0003964
hiv1_reverse_transcription HIV-1 reverse transcription BIOLOGICAL_PROCESS REVIEWED_LABEL_ONLY
Edges — nevirapine_hiv1_reverse_transcriptase_inhibition
SubjectPredicateObjectEvidence
nevirapine opens and occupies nnrti_pocket
  • PMID:22266819 (Crystal structures of HIV-1 RT-DNA-nevirapine and comparator complexes resolve nevirapine in the NNRTI pocket.)
nnrti_pocket displaces primer_active_site_alignment
  • PMID:22266819 (Das and colleagues observed nevirapine-associated primer displacement and distortion of the dNTP-binding pocket in RT-DNA crystals.)
primer_active_site_alignment is required for rna_directed_dna_polymerase_activity
  • PMID:22266819 (RT-DNA-nevirapine structural comparisons support the allosteric block between NNRTI-pocket occupancy and polymerase activity.)
rna_directed_dna_polymerase_activity is required for hiv1_reverse_transcription
  • PMID:1377403 (The first HIV-1 reverse transcriptase-inhibitor crystal structure supports reverse transcriptase as a viral DNA polymerase drug target.)

Curation history

  1. SEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Seeded from data/raw/ inventories (CHEBI)

  2. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  3. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  4. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  5. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  6. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  7. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  8. CURATED_CAUSAL_GRAPH 2026-09-04 · codex · LLM-assisted

    Added a PMID-supported causal graph for nevirapine allosteric inhibition of HIV-1 reverse transcriptase.

Provenance

Seeded by scripts/seed_from_sources.py from the committed inventories in data/raw/. View the record.